AHL
Abel Hall LLC Portfolio holdings
AUM
$216M
1-Year Return
17.12%
This Quarter Return
+9.62%
1 Year Return
+17.12%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$216M
AUM Growth
+$50.6M
(+31%)
Cap. Flow
+$37.6M
Cap. Flow
% of AUM
17.36%
Top 10 Holdings %
Top 10 Hldgs %
43.1%
Holding
328
New
126
Increased
90
Reduced
60
Closed
39
Top Buys
| 1 |
Microsoft
MSFT
|
$1.25M |
| 2 |
Whirlpool
WHR
|
$1.21M |
| 3 |
Avantis US Equity ETF
AVUS
|
$1.13M |
| 4 |
NVIDIA
NVDA
|
$1.03M |
| 5 |
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
|
$930K |
Top Sells
| 1 |
VICI Properties
VICI
|
$723K |
| 2 |
Dimensional International Core Equity 2 ETF
DFIC
|
$533K |
| 3 |
Johnson & Johnson
JNJ
|
$443K |
| 4 |
Agree Realty
ADC
|
$396K |
| 5 |
Gilead Sciences
GILD
|
$315K |
Sector Composition
| 1 | Technology | 11.06% |
| 2 | Financials | 6.83% |
| 3 | Energy | 5.7% |
| 4 | Consumer Discretionary | 4.46% |
| 5 | Healthcare | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SABA
251
Saba Capital Income & Opportunities Fund II
SABA
$257M
| $91.9K | 0.04% |
+10,000
| New | +$91.9K |
|
252
Genworth Financial
GNW
$3.52B
| $87.6K | 0.04% |
11,262
+1,226
| +12% | +$9.54K |
|
|
ETW
253
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$974M
| $86.5K | 0.04% |
10,000
| – | – |
|
|
OXLC
254
Oxford Lane Capital
OXLC
$1.75B
| $84K | 0.04% |
+20,000
| New | +$84K |
|
255
Patterson-UTI
PTEN
$2.18B
| $81.9K | 0.04% |
+13,816
| New | +$81.9K |
|
256
Lumen
LUMN
$4.87B
| $75.5K | 0.03% |
17,226
-6,268
| -27% | -$27.5K |
|
257
Transocean
RIG
$2.9B
| $67.1K | 0.03% |
25,891
+15,037
| +139% | +$38.9K |
|
258
Marqeta
MQ
$2.76B
| $60.8K | 0.03% |
+10,428
| New | +$60.8K |
|
259
NovaGold Resources
NG
$2.75B
| $47K | 0.02% |
+11,502
| New | +$47K |
|
260
indie Semiconductor
INDI
$854M
| $41.2K | 0.02% |
+11,568
| New | +$41.2K |
|
261
Akebia Therapeutics
AKBA
$785M
| $38.7K | 0.02% |
+10,618
| New | +$38.7K |
|
262
Clarus
CLAR
$141M
| $37.2K | 0.02% |
+10,718
| New | +$37.2K |
|
263
Sera Prognostics
SERA
$127M
| $30.6K | 0.01% |
+11,037
| New | +$30.6K |
|
264
Plug Power
PLUG
$1.69B
| $30K | 0.01% |
+20,110
| New | +$30K |
|
265
Ring Energy
REI
$207M
| $28.1K | 0.01% |
+35,380
| New | +$28.1K |
|
|
HPP
266
Hudson Pacific Properties
HPP
$1.16B
| $27.6K | 0.01% |
+10,082
| New | +$27.6K |
|
267
Traeger
COOK
$200M
| $21K | 0.01% |
+12,292
| New | +$21K |
|
268
SES AI
SES
$395M
| $20.5K | 0.01% |
23,063
+1,106
| +5% | +$982 |
|
269
Tilly's
TLYS
$57.3M
| $19.5K | 0.01% |
+14,105
| New | +$19.5K |
|
270
Chegg
CHGG
$185M
| $17.9K | 0.01% |
14,794
+1,929
| +15% | +$2.33K |
|
271
Tevogen Bio Holdings
TVGN
$170M
| $17.7K | 0.01% |
14,174
-1,142
| -7% | -$1.43K |
|
272
Harvard Bioscience
HBIO
$21.3M
| $16.6K | 0.01% |
+37,334
| New | +$16.6K |
|
273
Pacific Biosciences
PACB
$381M
| $14.9K | 0.01% |
+11,983
| New | +$14.9K |
|
274
C4 Therapeutics
CCCC
$194M
| $14.6K | 0.01% |
+10,225
| New | +$14.6K |
|
|
BOLD
275
Boundless Bio
BOLD
$25.7M
| $14.5K | 0.01% |
+14,399
| New | +$14.5K |
|